Similar articles

• Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.

  Oberg K, Jelic S; ESMO Guidelines Working Group. Oberg K, et al. Ann Oncol. 2008 May;19 Suppl 2:ii104-5. doi: 10.1093/annonc/mdn117. Ann Oncol. 2008. PMID: 18456741 No abstract available.
• Neuroendocrine bronchial and thymic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  Oberg K, Hellman P, Kwekkeboom D, Jelic S; ESMO Guidelines Working Group. Oberg K, et al. Ann Oncol. 2010 May;21 Suppl 5:v220-2. doi: 10.1093/annonc/mdq191. Ann Oncol. 2010. PMID: 20555085 No abstract available.
• Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.

  Ramage JK, Davies AH, Ardill J, Bax N, Caplin M, Grossman A, Hawkins R, McNicol AM, Reed N, Sutton R, Thakker R, Aylwin S, Breen D, Britton K, Buchanan K, Corrie P, Gillams A, Lewington V, McCance D, Meeran K, Watkinson A; UKNETwork for Neuroendocrine Tumours. Ramage JK, et al. Gut. 2005 Jun;54 Suppl 4(Suppl 4):iv1-16. doi: 10.1136/gut.2004.053314. Gut. 2005. PMID: 15888809 Free PMC article. No abstract available.
• Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendation for diagnosis, treatment and follow-up.

  Oberg K, Jelic S; ESMO Guidelines Working Group. Oberg K, et al. Ann Oncol. 2009 May;20 Suppl 4:150-3. doi: 10.1093/annonc/mdp158. Ann Oncol. 2009. PMID: 19454440 Review. No abstract available.
• Current Concepts in the Management of GEP-NETs: Introduction.

  Iyer R. Iyer R. Clin Adv Hematol Oncol. 2016 Apr;14(4 Suppl 6):3-4. Clin Adv Hematol Oncol. 2016. PMID: 27167990 Review. No abstract available.